Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
STML

Stemline

$19.25

(0.00%)

07:25
05/17/18
05/17
07:25
05/17/18
07:25
Hot Stocks
Stemline to present SL-801, SL-701 clinical data at ASCO »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$18.25

0.5 (2.82%)

16:01
05/09/18
05/09
16:01
05/09/18
16:01
Earnings
Stemline reports Q1 EPS (69c), consensus (69c) »

Stemline ended Q1 with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$17.15

-0.55 (-3.11%)

, KPTI

Karyopharm

$13.09

-2.04 (-13.48%)

07:23
05/01/18
05/01
07:23
05/01/18
07:23
Recommendations
Stemline, Karyopharm analyst commentary at H.C. Wainwright »

H.C. Wainwright…

STML

Stemline

$17.15

-0.55 (-3.11%)

KPTI

Karyopharm

$13.09

-2.04 (-13.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

Over a month ago
STML

Stemline

$17.00

0.15 (0.89%)

07:12
04/26/18
04/26
07:12
04/26/18
07:12
Hot Stocks
Stemline announces clinical presentations of SL-801, SL-701 at ASCO »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$15.55

0.85 (5.78%)

07:13
04/05/18
04/05
07:13
04/05/18
07:13
Hot Stocks
Stemline announces start of rolling BLA submission for SL-401 »

Stemline Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STML

Stemline

$15.00

-1.25 (-7.69%)

07:32
03/16/18
03/16
07:32
03/16/18
07:32
Earnings
Breaking Earnings news story on Stemline »

Stemline reports Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
STML

Stemline

$14.15

-0.1 (-0.70%)

07:03
01/24/18
01/24
07:03
01/24/18
07:03
Syndicate
Stemline 3.7M share Secondary priced at $14.00 »

JPMorgan and Cowen acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

STML

Stemline

$14.25

0.7 (5.17%)

09:55
01/23/18
01/23
09:55
01/23/18
09:55
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

STML

Stemline

$14.25

0.7 (5.17%)

04:55
01/23/18
01/23
04:55
01/23/18
04:55
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

STML

Stemline

$14.25

0.7 (5.17%)

17:47
01/22/18
01/22
17:47
01/22/18
17:47
Conference/Events
Stemline participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.